Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa vs TCM in Central Precocious Puberty
NCT02920515Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Sep 2012
- Primary completion
- Aug 2015
- Modality
- Peptides, Small Molecules
01
Overview
Phase 4, open-label trial of triptorelin and leuprolide in central precocious puberty (CPP) and precocious puberty (3 arms), sponsored by Ruijin Hospital. Primary endpoint: Comparisons of the height SDS'changes at 6 months. Started Sep 2012; status: completed.
02
Drugs
triptorelinleuprolide
03
Conditions
central precocious puberty (CPP)precocious puberty
Beyond the preview
Go deeper on NCT02920515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920515.